Patents by Inventor David E. Stec

David E. Stec has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220142980
    Abstract: Compositions and methods for the treatment of obesity, hyperlipidemia, fatty liver disease, cardiovascular disease and type II diabetes are described. Also described are compositions and methods for decreasing one or more of body weight, total fat, percent fat mass, visceral fat, epididymal fat, hepatic fat content, fasting blood glucose, decreasing white adipose fat (WAT) adipocyte size, or increasing percent lean mass. The compositions and methods involve PEGylated bilirubin.
    Type: Application
    Filed: February 18, 2020
    Publication date: May 12, 2022
    Applicant: The University of Toledo
    Inventors: Terry D. Hinds, Jr., David E. Stec
  • Patent number: 10662153
    Abstract: Thin molecules, compounds producible by cleaving bilirubin at its methylene site in the center of the molecule, methods of making the same, and methods of using the same, are described.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: May 26, 2020
    Assignee: The University of Toledo
    Inventors: Terry D. Hinds, Jr., David E. Stec, Christopher J. Trabbic
  • Publication number: 20190047952
    Abstract: Thin molecules, compounds producible by cleaving bilirubin at its methylene site in the center of the molecule, methods of making the same, and methods of using the same, are described.
    Type: Application
    Filed: February 27, 2017
    Publication date: February 14, 2019
    Applicant: The University of Toledo
    Inventors: Terry D. Hinds, Jr., David E. Stec, Christopher J. Trabbic